Articles by Jianxin Lin (7)

Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non-HDL-C, ApoB, and hs-CRP in patients with type 2 diabetes

Ruth S. Weinstock, Ronald B. Goldberg, John R. Guyton, Theodore Mazzone, Adam Polis, Joanne E. Tomassini, Jianxin Lin, Arvind Shah and Andrew M. Tershakovec

Journal of Clinical Lipidology 2 ( 1 ): 25 - 35 , 2008

Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein

Michael H. Davidson, Nicola Abate, Christie M. Ballantyne, Alberico L. Catapano, Xia Xu, Jianxin Lin, Elizabeth Rosenberg and Andrew M. Tershakovec

Journal of Clinical Lipidology 2 ( 6 ): 436 - 446 , 2008

Efficacy and tolerability of extended-release niacin/laropiprant in dyslipidemic patients with metabolic syndrome

Harold E. Bays, Arvind Shah, Jianxin Lin, Christine McCrary Sisk, John F. Paolini and Darbie Maccubbin

Journal of Clinical Lipidology 4 ( 6 ): 515 - 521 , 2010

Influence of simvastatin, fenofibrate and/or ezetimibe on correlation of low-density lipoprotein and nonhigh-density lipoprotein cholesterol with apolipoprotein B in mixed dyslipidemic patients

Michel Farnier, William Taggart, Qian Dong, Jianxin Lin, Arvind Shah and Philippe Brudi

Journal of Clinical Lipidology 5 ( 3 ): 179 - 187 , 2011

Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)

Jennifer G. Robinson, Christie M. Ballantyne, Willa Hsueh, Jeffrey Rosen, Jianxin Lin, Arvind Shah, Robert S. Lowe, Mary E. Hanson and Andrew M. Tershakovec

Journal of Clinical Lipidology 5 ( 6 ): 474 - 482 , 2011

Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome

Jennifer G. Robinson, Christie M. Ballantyne, Willa A. Hsueh, Jeffrey B. Rosen, Jianxin Lin, Arvind K. Shah, Joanne E. Tomassini, Robert S. Lowe and Andrew M. Tershakovec

Journal of Clinical Lipidology 7 ( 4 ): 292 - 303 , 2013

Synthesis and characterization of platinum(II) complexes with 2-imidazolidinethione. X-ray crystal structure of tetra(2-imidazolidinethione- S )platinum(II) iodide dimethylsulfoxide solvate monohydrate

Jianxin Lin, Guangyi Lu, Lee M. Daniels, Xin Wei, John B. Sapp and Yuanjian Deng

Journal of Coordination Chemistry 61 ( 15 ): 2457 - 2469 , 2008